All articles by Linda Stewart – Page 132
-
NewsAntibody-based therapy is several steps closer to treat lethal mucormycosis
A new paper discusses the use of monoclonal antibodies to target a key fungal cell surface protein, CotH, which enables the Mucorales fungus to invade human cells and cause mucormycosis, which has high mortality rates in people with weakened immune systems.
-
NewsA high-fat diet may impair response to infection
A new study in The Journal of Immunology reveals how a high-fat diet may impair the immune system’s ability to respond to infection by impacting the function of neutrophils, one of the first immune cells to respond to bacteria or viruses. The study demonstrated that male mice fed a high-fat ...
-
NewsNew model predicts how bacteria navigate obstacles to spread
A scientist has developed the first analytical model for predicting how bacteria spread in environments filled with obstacles. This model will help inform strategies for curbing bacterial infections or for designing better drug delivery.
-
NewsResearchers test new, more reliable method to detect chagas disease
Researchers have successfully tested a faster, more sensitive and reliable way to diagnose Chagas disease, a debilitating parasitic illness that affects approximately 6 million people worldwide.
-
NewsFrom pollution to polymer: Methane-munching microbe brews biodegradable plastic at high speed
Scientists have tapped into a methane-consuming bacterium, Methylocystis suflitae, to produce biodegradable plastics called polyhydroxyalkanoates (PHAs), offering a dual win for climate and sustainability.
-
NewsSelective G6PDH inactivation for Helicobacter pylori eradication with transformed polysulfide
A new study highlights a novel mechanism of action driven by polysulfides, presenting a promising alternative strategy for combating H. pylori infections.
-
NewsNature’s warriors: How rice plants detect and defend against viral invaders
A groundbreaking study uncovers a molecular mechanism by which rice cells perceive viral infections and initiate antiviral response, which significantly contributes to understanding of virus-host interactions for further disease resistance breeding.
-
NewsMcMaster leads Canada’s first-ever guidelines for Post COVID-19 Condition
A team of experts from McMaster University has led the creation of Canada’s first-ever comprehensive guidelines for diagnosing, managing, preventing, and treating post COVID-19 condition (PCC), more commonly known as long COVID.
-
NewsGatekeeping barriers manage communications between plants and bacteria
For over a century, the Casparian strip has been known as the root’s doorman, controlling what enters the plant. But a new study reveals it has a second job: regulating the delicate metabolic trade between plants and bacteria.
-
NewsFour advances that could change tuberculosis treatment
World Tuberculosis Day commemorates Robert Koch’s discovery of the source bacterium Mycobacterium tuberculosis. Scientists are still refining TB diagnosis methods and treatment strategies - some of the latest innovations are revealed here.
-
NewsTuberculosis in children and adolescents: EU/EEA observes a rise in 2023
The notification rate of tuberculosis (TB) went up from 2 to 2.5 per 100,000 population. But overall, numbers of notified paediatric cases remain relatively low across the region.
-
NewsEfficacy of topical Nigella sativa L. with vinegar in the treatment of acne vulgaris
A team of researchers in India assessed the efficacy and safety of a topical formulation combining Kalonji and Sirka for the treatment of mild to moderate acne vulgaris. The formulation was compared with a 5% benzoyl peroxide.
-
NewsJapanese plant Daphne pseudomezereum yields anti-HIV daphnane diterpenoids
Scientists have discovered for the first time that Daphne pseudomezereum (commonly known as Onishibari) contains a substance inhibiting replication of human immunodeficiency virus (HIV).
-
NewsAMI leaders join International Microbiome Meeting in San Diego
Leading scientists from around the world recently convened at the Center for Microbiome Innovation’s International Microbiome Meeting (CIMM) at the Scripps Institution of Oceanography in San Diego.
-
NewsGuardians of the vineyard: Canines and chemistry work to combat powdery mildew
Researchers are now analyzing volatile chemicals emanating from grape leaves infected by a fungus called powdery mildew with the goal of improving training for vineyard canines that use their noses to detect infected vines.
-
NewsStudy identifies viruses in red tide blooms for the first time
A new study identifies viruses associated with Karenia brevis, the single-celled organism that causes red tide. By testing water samples collected from red tide blooms, the researchers found several viruses in blooms — including one new viral species.
-
NewsNew study reveals high levels of fusarium mycotoxins in seized cannabis from Arizona and California
A recent study has uncovered alarming levels of Fusarium mycotoxins in illicit cannabis samples seized in Arizona and California. 16% of the 118 samples tested positive for harmful mycotoxins, posing potential health risks to consumers and highlighting the unregulated and dangerous nature of black-market cannabis.
-
NewsUnknown microorganisms used marble and limestone as a habitat
Research work has revealed unusual structures that are probably due to the activity of an unknown microbiological life form. Unusually small burrows, i.e., tiny tubes that run through the rock in a parallel arrangement from top to bottom, were discovered in marble and limestone of the desert areas of Namibia, Oman, and Saudi Arabia.
-
NewsTeam finds regional, age-related trends in exposure to drug-resistant pathogen
A study from 10 US states found drug-resistant Campylobacter jejuni infections were highest in the 20-39 age group and that quinolone-resistant C. jejuni infections increased from 22.6% of those tested in 2013 to 33.54% in 2019. It identified regional differences in C. jejuni resistance to quinolones and six other classes of antibiotics.
-
NewsStudy yields new data on Mpox vaccine effectiveness in people with HIV
A new study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer sufficient protection. All at-risk groups, especially people with HIV, should receive the second dose of the vaccine as recommended.